• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-肾上腺素能阻滞剂纳多洛尔(康加德)在预防动脉高血压中的作用:为期6个月的治疗(合作研究)

[Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].

作者信息

Metelitsa V I, Filatova N P

出版信息

Kardiologiia. 1990 May;30(5):8-14.

PMID:2202853
Abstract

A comparative study was undertaken to examine the long-acting beta-blocker nadolol without intrinsic sympathomimetic activity and reference agents such as anapriline, a beta-blocker, hypothiazide, a diuretic, and pratsiol, a postsynaptic alpha-adrenoblocker in 361 patients with sustained arterial hypertension (diastolic blood pressure, 95 mm Hg or more) in the randomized groups. The therapy was started with monotherapy of one of these drugs; if ineffective, a combination of two or, if necessary, three agents of different groups was given. The patients' status was monitored at least once monthly for 6 months. Monotherapy with beta-blockers or pratsiol was found to be more effective than that with diuretics. Addition of the second agent was required by 48% of the patients, that of the third agent, by 13%. Nadolol in combination with diuretics and/or pratsiol showed the same effects as did anapriline. The agent possessed a more pronounced negative chronotropic action than did anapriline when it was given alone or in combination. Nadolol caused a decrease in middle and small-sized bronchial patency as did anapriline. A 6-month nadolol therapy resulted in regression of left ventricular hypertrophy.

摘要

进行了一项比较研究,在361例持续性动脉高血压(舒张压95毫米汞柱或更高)患者的随机分组中,考察无内在拟交感活性的长效β受体阻滞剂纳多洛尔以及对照药物,如β受体阻滞剂阿那普利林、利尿剂氢氯噻嗪和突触后α肾上腺素能阻滞剂普拉西奥。治疗从使用这些药物之一进行单一疗法开始;如果无效,则给予两种药物的联合治疗,必要时给予三种不同组别的药物联合治疗。对患者的状况至少每月监测一次,持续6个月。发现使用β受体阻滞剂或普拉西奥进行单一疗法比使用利尿剂更有效。48%的患者需要添加第二种药物,13%的患者需要添加第三种药物。纳多洛尔与利尿剂和/或普拉西奥联合使用时显示出与阿那普利林相同的效果。单独给药或联合给药时,该药物比阿那普利林具有更明显的负性变时作用。纳多洛尔与阿那普利林一样,会导致中小支气管通畅性降低。为期6个月的纳多洛尔治疗导致左心室肥厚消退。

相似文献

1
[Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].β-肾上腺素能阻滞剂纳多洛尔(康加德)在预防动脉高血压中的作用:为期6个月的治疗(合作研究)
Kardiologiia. 1990 May;30(5):8-14.
2
[The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy].
Ter Arkh. 1991;63(8):30-4.
3
[The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion].[纳多洛尔、普萘洛尔、哌唑嗪和氢氯噻嗪在高血压患者12个月阶梯式治疗中的比较研究结果(合作研究)。预防高血压新制剂研究合作项目工作组。二、联合治疗结果。副作用。退出研究的原因。结论]
Ter Arkh. 1991;63(8):35-41.
4
[The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension].纳多洛尔与普萘洛尔短疗程治疗高血压患者的比较结果(合作研究)。预防高血压新制剂研究合作项目工作组
Ter Arkh. 1989;61(12):30-6.
5
Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
Am Heart J. 1984 Oct;108(4 Pt 2):1087-91. doi: 10.1016/0002-8703(84)90586-6.
6
[Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].[在一项预防动脉高血压新药合作研究中,哌唑嗪(普拉齐奥)与肼屈嗪(阿普利辛)短疗程治疗的降压效果及耐受性]
Kardiologiia. 1985 Jan;25(1):23-8.
7
Initial therapy of essential hypertension: diuretic or beta blocker?原发性高血压的初始治疗:利尿剂还是β受体阻滞剂?
J Fam Pract. 1980 Aug;11(2):199-205.
8
Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).
Am J Cardiol. 1988 Jan 1;61(1):117-21. doi: 10.1016/0002-9149(88)91316-1.
9
Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.纳多洛尔与氢氯噻嗪对原发性高血压的长期治疗:两年随访
J Int Med Res. 1982;10(2):87-91. doi: 10.1177/030006058201000203.
10
A comparison of prazosin versus nadolol in combination with a diuretic.
Am J Cardiol. 1984 Jan 27;53(3):37A-39A. doi: 10.1016/0002-9149(84)90834-8.